RxDoctor Payments Data

Joel Epstein

Pulmonary Disease · Lakewood, CANPI 1013037779

Payments from drug & device makers

$4,722in general payments, 2019–2025

Across 238 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$1K
  • GSK$741
  • AstraZeneca$712
  • AbbVie$627
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$412
  • Mylan Specialty L.p.$400
  • plus $822 from 17 others

What the payments were for

  • Speaking & faculty fees$58312%
  • Food & beverage$4,12787%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,722 in reported general payments places this provider in the 65th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Other pulmonary disease in Lakewood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →